Patients report a reduction in pain scores after receiving targeted drug delivery.
Targeted drug delivery (TDD) provides effective pain relief by delivering medication directly to the fluid surrounding the spinal cord via a programmable pump.1-5
Targeted drug delivery is an option for cancer pain management and is commonly known as a “pain pump.”
Under specific conditions. Talk to your doctor and refer to product labeling for full list of conditions.
Smith TJ, Staats PS, Deer T, et al. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J Clin Oncol. 2002;20:4040-4049.
Ruan X. Drug-related side effects of long-term intrathecal morphine therapy. Pain Physician. 2007;10:357-366.
Stearns LM, Abd-Elsayed A, Perruchoud C, et al. Intrathecal Drug Delivery Systems for Cancer Pain: An Analysis of a Prospective, Multicenter Product Surveillance Registry. Anesth Analg. 2020;130(2):289-297.
Brogan SE, Sindt JE, et al. Prospective Association of Serum Opioid Levels and Clinical Outcomes in Patients With Cancer Pain Treated With Intrathecal Opioid Therapy. Anesth Analg. 2019 Jun 12. doi: 10.1213/ANE.0000000000004276. [Epub ahead of print]
Carvajal G, Dupoiron D, Seegers V, et al. Intrathecal Drug Delivery Systems for Refractory Pancreatic Cancer Pain: Observational Follow-Up Study Over an 11-Year Period in a Comprehensive Cancer Center. Anesth Analg. 2018;14:14.
Information on this site should not be used as a substitute for talking with your doctor. Always talk with your doctor about diagnosis and treatment information.